EE403 Health and Economic Impact of a Novel 3-Antigen Vaccine for the Prevention of Hepatitis B in Adults in Germany: A Cost-Effectiveness Analysis
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.649
https://www.valueinhealthjournal.com/article/S1098-3015(22)02853-4/fulltext
Title :
EE403 Health and Economic Impact of a Novel 3-Antigen Vaccine for the Prevention of Hepatitis B in Adults in Germany: A Cost-Effectiveness Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02853-4&doi=10.1016/j.jval.2022.09.649
First page :
Section Title :
Open access? :
No
Section Order :
10186